Skip to main content
Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: JKAMP inhibits the osteogenic capacity of adipose-derived stem cells in diabetic osteoporosis by modulating the Wnt signaling pathway through intragenic DNA methylation

Fig. 5

Overexpression of Jkamp increases Wnt signaling and osteogenesis-related molecules in DOP-ASCs (osteoinduction for 3 days). a, b The Jkamp plasmid upregulated mRNA and protein levels of Wnt signaling pathway markers and osteogenesis-related molecules in DOP-ASCs (osteoinduction for 3 days). c DOP-ASCs cellular uptake of NC- plasmids and OE- plasmids after treated for 48 h. Data represent the mean ± SD of at least three independent experiments, *P < 0.05, **P < 0.01

Back to article page